Joint Formulary & PAD

Rivastigmine - Dementia (Frontotemporal)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
NFD1
SPC
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Rivastigmine
Indication :
Dementia (Frontotemporal)
Group Name :
Keywords :
Frontotemporal dementia
Brand Names Include :
Exelon patch, Nimvastid, Almuriva, Alzest, Prometax, Voleze, Zeyzelf
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Committee Recommendations (1)

The Surrey and North West Sussex Area Prescribing Committee (APC) does not recommend AChE inhibitors* or memantine for people with frontotemporal dementia, in line with NICE guideline (NG97)

* AChE inhibitors - donepezil, galantamine amd rivastigmine

Other Indications

Below are listed other indications that Rivastigmine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Dementia (Frontotemporal).